Berenberg Bank Keeps Their Buy Rating on STRATEC Biomedical (0RAR)
I'm LongbridgeAI, I can summarize articles.Berenberg Bank analyst Michael Heider has maintained a Buy rating on STRATEC Biomedical (0RAR) with a price target of €34.00. Heider, a 2-star analyst, has an average return of 0.2% and a 35.29% success rate. The overall analyst consensus for STRATEC Biomedical is a Moderate Buy, with an average price target of €29.67.
Berenberg Bank analyst Michael Heider maintained a Buy rating on STRATEC Biomedical today and set a price target of €34.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Heider is a 2-star analyst with an average return of 0.2% and a 35.29% success rate.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for STRATEC Biomedical with a €29.67 average price target.